Image

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

Investigating Gut Microbiome Modulation in Resectable Pancreatic Cancer

Recruiting
19 years and older
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates resectable pancreatic cancer. It explores how the gut microbiome is affected by treatment with antibiotics and an investigational medication after chemotherapy.

The purpose of this study is to evaluate the immune response and safety of combining antibiotics with an investigational medication. It looks at how these treatments may impact the cancer and the body's immune system.

  • Who can participate: Adults over 18 years with resectable pancreatic cancer and a good performance status can participate. They must agree to biopsies and surgical procedures.
  • Study details: Participants will receive antibiotics and an investigational medication after chemotherapy.
  • Study timelines: The study will last 5 years. Participant involvement is 6 months.
Print
Study details
    Pancreatic Cancer

NCT05462496

Icahn School of Medicine at Mount Sinai

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.